BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 204 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,180,391 | -0.7% | 340,141 | +31.8% | 0.05% | +4.3% |
| Q2 2023 | $8,237,653 | +27.1% | 257,991 | +21.9% | 0.05% | +4.5% |
| Q1 2023 | $6,481,274 | -14.9% | 211,668 | +8.7% | 0.04% | -31.2% |
| Q4 2022 | $7,615,695 | +29.0% | 194,725 | +57.1% | 0.06% | +1.6% |
| Q3 2022 | $5,904,000 | +26.1% | 123,925 | +2.4% | 0.06% | +46.5% |
| Q2 2022 | $4,683,000 | -9.6% | 120,973 | +33.8% | 0.04% | +38.7% |
| Q1 2022 | $5,179,000 | -11.9% | 90,383 | +22.5% | 0.03% | 0.0% |
| Q4 2021 | $5,879,000 | +136.2% | 73,779 | +157.9% | 0.03% | +82.4% |
| Q3 2021 | $2,489,000 | -34.2% | 28,606 | -2.7% | 0.02% | -29.2% |
| Q2 2021 | $3,783,000 | +39.6% | 29,390 | -13.2% | 0.02% | +26.3% |
| Q1 2021 | $2,710,000 | +206.6% | 33,854 | +212.7% | 0.02% | +111.1% |
| Q4 2020 | $884,000 | – | 10,825 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $189,105,000 | 91.90% |
| PATHWAY CAPITAL MANAGEMENT, LP | 37,399 | $2,993,000 | 16.59% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,390 | $17,960,000 | 10.54% |
| HSG Holding Ltd | 796,089 | $63,719,000 | 4.73% |
| DC Investments Management, LLC | 21,010 | $1,682,000 | 4.17% |
| Monashee Investment Management LLC | 268,820 | $21,516,000 | 3.31% |
| Redmile Group, LLC | 2,532,523 | $202,703,000 | 2.86% |
| HAMILTON LANE ADVISORS LLC | 98,761 | $7,905,000 | 2.58% |
| Alphabet Inc. | 640,792 | $51,289,000 | 2.07% |
| Casdin Capital, LLC | 818,820 | $65,538,000 | 1.95% |